David M. Mott
Executive Chairman,3-V Biosciences, Inc.
|Age||Total Calculated Compensation||This person is connected to 189 board members in 16 different organizations across 24 different industries.|
See Board Relationships
Mr. David M. Mott, also known as Dave, has been the General Partner of New Enterprise Associates since September 17, 2008 and serves as its Partner. Mr. Mott focuses on healthcare and biopharmaceuticals investments and leads the New Enterprise healthcare investing practice. He serves as Partner and General Partner of New Enterprise Associates 14, L.P. He serves as a Senior Advisor of The Royal Institute of International Affairs. He serves as a Senior Advisor of Chatham ...
1050 Hamilton CourtPhone: 650-561-8600
Menlo Park, California 94025
Board Members Memberships*
Member of the Board of Directors
Independent Director and Chairman of Compensation Committee
Chairman, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.